1. |
Hauser WA, Annegers JF, Kurland LT. Incidence of epilepsy and unprovoked seizures in rochester, Minnesota: 1935-1984. Epilepsia, 1993, 34(3): 453-468.
|
2. |
Olafsson E, Ludvigsson P, Gudmundsson G, et al. Incidence of unprovoked seizures and epilepsy in Iceland and assessment of the epilepsy syndrome classification: a prospective study. Lancet Neurol, 2005, 4(10): 627-634.
|
3. |
Spatola M, Dalmau J. Seizures and risk of epilepsy in autoimmune and other inflammatory encephalitis. Curr Opin Neurol, 2017, 30(3): 345-353.
|
4. |
Irani SR, Alexander S, Waters P, et al. Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis. Morvan’s syndrome and acquired neuromyotonia. Brain, 2010, 133(9): 2734-2748.
|
5. |
Graus F, Titulaer MJ, Balu R, et al. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol, 2016, 15(4): 391-404.
|
6. |
Gultekin SH, Rosenfeld MR, Voltz R, et al. Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients. Brain, 2000, 123(7): 1481-1494.
|
7. |
Bien CG, Schulze-Bonhage A, Deckert M, et al. Limbic encephalitis not associated with neoplasm as a cause of temporal lobe epilepsy. Neurology, 2000, 55(12): 1823-1828.
|
8. |
Vincent A, Buckley C, Schott JM, et al. Potassium channel antibodyassociatedencephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis. Brain, 2004, 127(Pt 3): 701-712.
|
9. |
Lai M, Huijbers MG, Lancaster E, et al. Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series. Lancet Neurol, 2010, 9(8): 776-785.
|
10. |
Lai M, Hughes EG, Peng X, et al. AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location. Ann Neurol, 2009, 65(4): 424-434.
|
11. |
Carvajal-Gonzalez A, Leite MI, Waters P, et al. Glycine receptor antibodies in PERM and related syndromes: characteristics, clinical features and outcomes. Brain, 2014, 137(Pt 8): 2178-2192.
|
12. |
Boronat A, Gelfand JM, Gresa-Arribas N, et al. Encephalitis and antibodies to dipeptidyl-peptidase-like protein-6, a subunit of Kv4.2 potassium channels. Ann Neurol, 2013, 73(1): 120-128.
|
13. |
Lancaster E, Martinez-Hernandez E, Titulaer MJ, et al. Antibodies to metabotropic glutamate receptor 5 in the ophelia syndrome. Neurology, 2011, 77(18): 1698-1701.
|
14. |
Lancaster E, Lai M, Peng X, et al. Antibodies to the GABA(b) receptor in l imbic encephalitis with seizures: case series and characterisation of the antigen. Lancet Neurol, 2010, 9(1): 67-76.
|
15. |
Malter MP, Helmstaedter C, Urbach H, et al. Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis. Ann Neurol, 2010, 67(4): 470-478.
|
16. |
Stefan H, May TW, Pfafflin M, et al. Epilepsy in the elderly: comparingclinical characteristics with younger patients. Acta Neurol Scand, 2014, 129(5): 283-293.
|
17. |
Bien CG, Mirzadjanova Z, Baumgartner C, et al. Anti-contactin-associated protein-2 encephalitis: relevance of antibody titres, presentation and outcome. Eur J Neurol, 2017, 24(1): 175-186.
|
18. |
van Sonderen A, Schreurs MW, de Bruijn MA, et al. The relevance of VGKC positivity in the absence of LGI1 and caspr2 antibodies. Neurology, 2016, 86(18): 1692-1699.
|
19. |
Lang B, Makuch M, Moloney T, et al. Intracellular and non-neuronal targets of voltage-gated potassium channel complex antibodies. J Neurol Neurosurg Psychiatry, 2017, 88(4): 353-361.
|
20. |
Bataller L, Kleopa KA, Wu GF, et al. Autoimmune limbic encephalitis in 39 patients: immunophenotypes and outcomes. J Neurol Neurosurg Psychiatry, 2007, 78(4): 381-385.
|
21. |
van Sonderen A, Ari~no H, Petit-Pedrol M, et al. The clinical spectrum of caspr2 antibody-associated disease. Neurology, 2016, 87(5): 521-528.
|
22. |
van Sonderen A, Schreurs MWJ, Wirtz PW, et al. From VGKC to LGI1 and CASPR2 encephalitis: the evolution of a disease entity over time. Autoimmun Rev, 2016, 15(10): 970-974.
|
23. |
Joubert B, Saint-Martin M, Noraz N, et al. Characterization of a subtype of autoimmune encephalitis with anti-contactinassociated protein-like2 antibodies in the cerebrospinal fluid, prominent limbic symptoms, and seizures. JAMA Neurol, 2016, 73(9): 1115-1124.
|
24. |
da Rocha AJ, Nunes RH, Maia ACM, et al. Recognizing autoimmunemediated encephalitis in the differential diagnosis of limbic disorders. AJNR Am J Neuroradiol, 2015, 36(12): 2196-2205.
|
25. |
Urbach H, Soeder BM, Jeub M, et al. Serial MRI of limbic encephalitis. Neuroradiology, 2006, 48(6): 380-386.
|
26. |
Leypoldt F, Armangue T, Dalmau J. Autoimmune encephalopathies. Ann N Y Acad Sci, 2015, 1338: 94-114.
|
27. |
Huda S, Wong SH, Pettingill P, et al. An 11-year retrospective experience of antibodies against the voltage-gated potassium channel (VGKC) complex from a tertiary neurological centre. J Neurol, 2015, 262(2): 418-424.
|